STAAR Surgical (STAA) Misses Q4 EPS by 1c, provides guidance

STAAR Surgical (NASDAQ: STAA) reported Q4 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $76.3 million versus the consensus estimate of $75.94 million.

GUIDANCE:

STAAR Surgical sees FY2024 revenue of $335-340 million, versus the consensus of $337.7 million. Adjusted EBITDA of approximately $36 million and Adjusted EBITDA per diluted share of approximately $0.70.2

For earnings history and earnings-related data on STAAR Surgical (STAA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• Accenture downgraded by TD Cowen on AI concerns